Lataa...
HLA class I loss and PD-L1 expression in lung cancer: impact on T-cell infiltration and immune escape
Immune-checkpoint inhibitors show encouraging results in cancer treatment, but the clinical benefit is limited exclusively to a subset of patients. We analyzed the density and composition of tumor T-cell infiltration in non-small-cell lung carcinoma (NSCLC) in relation to PD-L1 and HLA class I (HLA-...
Tallennettuna:
| Julkaisussa: | Oncotarget |
|---|---|
| Päätekijät: | , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Impact Journals LLC
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5790526/ https://ncbi.nlm.nih.gov/pubmed/29423109 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.23469 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|